Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02717884
Title Study of Sensitization of Non-M3 AML Blasts to ATRA by Epigenetic Treatment With Tranylcypromine (TCP) (TRANSATRA)
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Michael Luebbert
Indications

chronic myelomonocytic leukemia

myelodysplastic syndrome

acute myeloid leukemia

Therapies

Cytarabine + Tranylcypromine + Tretinoin

Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
Universitätsklinikum Heidelberg Recruiting Heidelberg Baden-Wuerttemberg 69120 Germany Details
Universitätsklinik Düsseldorf, Medical School Duesseldorf Recruiting Düsseldorf 40225 Germany Details
Universitätsklinikum Frankfurt Main, Medical School Frankfurt Recruiting Frankfurt Main 60590 Germany Details
Universitätsklinikum Freiburg, Medical School Freiburg Recruiting Freiburg 79106 Germany Details
Klinikum München rechts der Isar, Medical School Munich rechts der Isar Recruiting München, Munich 81675 Germany Details
Universitätsklinikum Tübingen, Medical School Tuebingen Recruiting Tübingen, Tuebingen 72076 Germany Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field